Evidence map›Paper›PMID 25540093›Full record

ReviewReviews in endocrine & metabolic disorders2015

The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome.

Zhiguo Zhang, Shanshan Zhou, Xin Jiang, Yue-Hui Wang, Fengsheng Li, Yong-Gang Wang, Yang Zheng, Lu Cai

Abstract readReview
PubMed Publisher
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Nutrients · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Protective Effects of Curcumin and its AnaloguesCurrent medicinal chemistry · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Plants (Basel, Switzerland) · 2022
    Article
  15. The Nrf2 in Obesity: A Friend or Foe?Antioxidants (Basel, Switzerland) · 2022
    Review
  16. Article
  17. Oxidative Stress, Genomic Integrity, and Liver Diseases.Molecules (Basel, Switzerland) · 2022
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Zhiguo ZhangDepartments of Cardiovascular Disorders, Gerontology & Radiation Oncology at the First Hospital, Jilin University, Changchun, 130021, China.
Shanshan Zhou
Xin Jiang
Yue-Hui Wang
Fengsheng Li
Yong-Gang Wang
Yang Zheng
Lu Cai
Kosair Children's Hospital · USBaxter (United States) · USFirst Hospital of Jilin University · CNJilin University · CNUniversity of Louisville · USUniversity of Louisville Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear factor erythroid 2 related factor 2 (Nrf2) is a key regulator of antioxidant signaling that may prevent the development of metabolic syndrome and related cardiovascular diseases. However, emerging evidence shows that lack of Nrf2 could ameliorate insulin resistance, adipogenesis and adipocyte differentiation. Consistent with this, overexpression of Nrf2 gene could also cause insulin resistance under certain conditions. Furthermore, an increasing number of studies indicate that redox balance can be a critical element that contributes to the contradictory effects of Nrf2 on insulin sensitivity and resistance. Reactive oxygen species can promote normal insulin-mediated signal transduction under physiological conditions but also induce insulin resistance under certain pathological conditions. Therefore, the contradictory effects of Nrf2 on insulin signaling pathways may be related to its regulation of redox homeostasis. This review attempts to summarize the latest developments in our understanding of the mechanisms of Nrf2-mediated signaling and its role in the modulation of metabolic homeostasis.

Indexed as

HomeostasisHumansInsulin ResistanceIntracellular Signaling Peptides and ProteinsKelch-Like ECH-Associated Protein 1Metabolic SyndromeNF-E2-Related Factor 2ObesityReactive Oxygen SpeciesSignal TransductionIntracellular Signaling Peptides and ProteinsKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen Species

Identifiers

PMID25540093
OpenAlexW2012395662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.